10/06/2014 - 19:40
CHICAGO – Treating diarrhea-predominant irritable bowel syndrome with mesalazine for 12 weeks failed to improve stool frequency or other symptoms, compared with placebo, in a multicenter, randomized...
Field of Interest: Gastroentero...
Categories:
News Feed: Internal Medicine News - Gastroenterology